Se-cure Pharmaceuticals Ltd.

Israel

Back to Profile

1-4 of 4 for Se-cure Pharmaceuticals Ltd. Sort by
Query
Patent
Aggregations Reset Report
Jurisdiction
        World 2
        Canada 1
        United States 1
Date
2021 2
Before 2020 2
IPC Class
A01C 1/02 - Germinating apparatusDetermining germination capacity of seeds or the like 2
G01N 33/15 - Medicinal preparations 2
A01G 22/40 - Fabaceae, e.g. beans or peas 1
A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids 1
A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae 1
See more
Found results for  patents

1.

Methods and devices for a seed germination profile indicator based on electrical conductivity

      
Application Number 16726901
Grant Number 11051443
Status In Force
Filing Date 2019-12-25
First Publication Date 2021-07-01
Grant Date 2021-07-06
Owner Se-cure Pharmaceuticals Ltd (Israel)
Inventor Gutterman, Ron

Abstract

The present invention discloses methods and devices for a germination profile indicator based on conductivity including: utilizing a target-profile correlation of a target profile of an API from a plant seed to a target germination stage, the target profile includes identifying characteristics of chemical components, and wherein the target germination stage relates to a progress of a seed-germination process of the target profile; utilizing a process-profile correlation of germination-process profiles during the seed-germination process to respective process germination stages, wherein each germination-process profile relates to extracted seed material during the respective process germination stage; comparing characteristics of the target profile to corresponding features in the germination-process profiles; selecting an optimal state of the respective process germination stage to maximize an API quantity; and cross-correlating the optimal state to a conductivity range for the seed in a soak water within a given temperature range to identify a temperature-dependent germination stopping condition.

IPC Classes  ?

  • G01N 33/15 - Medicinal preparations
  • A01C 1/02 - Germinating apparatusDetermining germination capacity of seeds or the like
  • G01N 33/00 - Investigating or analysing materials by specific methods not covered by groups
  • A01G 22/40 - Fabaceae, e.g. beans or peas
  • G01N 30/02 - Column chromatography
  • G16C 60/00 - Computational materials science, i.e. ICT specially adapted for investigating the physical or chemical properties of materials or phenomena associated with their design, synthesis, processing, characterisation or utilisation

2.

METHODS AND DEVICES FOR A SEED GERMINATION PROFILE INDICATOR BASED ON ELECTRICAL CONDUCTIVITY

      
Document Number 03102534
Status In Force
Filing Date 2020-12-11
Open to Public Date 2021-06-25
Grant Date 2025-02-18
Owner SE-CURE PHARMACEUTICALS LTD. (Israel)
Inventor Gutterman, Ron

Abstract

The present invention discloses methods and devices for a germination profile indicator based on conductivity including: utilizing a target-profile correlation of a target profile of an API from a plant seed to a target germination stage, the target profile includes identifying characteristics of chemical components, and wherein the target germination stage relates to a progress of a seed-germination process of the target profile; utilizing a process-profile correlation of germination-process profiles during the seed-germination process to respective process germination stages, wherein each germination-process profile relates to extracted seed material during the respective process germination stage; comparing characteristics of the target profile to corresponding features in the germination-process profiles; selecting an optimal state of the respective process germination stage to maximize an API quantity; and cross-correlating the optimal state to a conductivity range for the seed in a soak water within a given temperature range to identify a temperature-dependent germination stopping condition.

IPC Classes  ?

  • A01C 1/02 - Germinating apparatusDetermining germination capacity of seeds or the like
  • G01N 30/86 - Signal analysis
  • G16C 20/00 - Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures

3.

A NOVEL DT56A COMPOUND WITH NOVEL CHARACTERISTICS

      
Application Number IL2012000350
Publication Number 2013/046199
Status In Force
Filing Date 2012-09-24
Publication Date 2013-04-04
Owner SE-CURE PHARMACEUTICALS LTD (Israel)
Inventor Gutterman, Ron

Abstract

The present invention provides a DT56a compound having Estrogen Receptor (ER) activating characteristics on at least a first portion of tissues or tissue parts and lack of substantially ER activation or ER blocking characteristics on at least a second portion of tissues or tissue parts. The aforementioned compound is quantitatively determined by at least one bioassay. The present invention further provides methods for validating a DT56a compound having SERM activity characteristics.

IPC Classes  ?

  • A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
  • G01N 33/15 - Medicinal preparations

4.

COMPOUNDS AND METHODS FOR THE TREATMENT OF MENOPAUSE AND BONE RELATED DISORDERS

      
Application Number IL2007000827
Publication Number 2008/004223
Status In Force
Filing Date 2007-07-03
Publication Date 2008-01-10
Owner SE-CURE PHARMACEUTICALS LTD. (Israel)
Inventor Gutterman, Ron

Abstract

There is provided a method for treating a menopausal symptom, which may include administering an effective amount of a Femarelle (DT56a) compound to a female suffering from a menopausal symptom. Also provided is a method for treating a bone density disorder, which may include administering a Femarelle (DT56a) compound to a subject suffering form bone density disorder. Bone density disorder may include osteopenia, osteoporosis, age-related bone disorder or any combination thereof. Also provided is a method for of inhibiting estrogen binding to estrogen receptors (ER) in a uterus, the method comprising administering an effective amount of a Femarelle (DT56a) to a female. Also provided is a method for inhibiting estrogen binding to estrogen receptors (ER) in a breast tissue, the method may include administering an effective amount of a Femarelle (DT56a) to a female.

IPC Classes  ?

  • A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids